Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the lifelines cohort study

Inflammation is associated with a range of neuropsychiatric symptoms, but the issue of causality remains unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational psychiatry Jg. 15; H. 1; S. 164 - 14
Hauptverfasser: Mac Giollabhui, Naoise, Slaney, Chloe, Hemani, Gibran, Foley, Éimear M., van der Most, Peter J., Nolte, Ilja M., Snieder, Harold, Davey Smith, George, Khandaker, Golam M., Hartman, Catharina A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 10.05.2025
Nature Publishing Group
Schlagworte:
ISSN:2158-3188, 2158-3188
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Inflammation is associated with a range of neuropsychiatric symptoms, but the issue of causality remains unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognition. We tested in ≈55,098 (59% female) individuals from the Dutch Lifelines cohort the concurrent/prospective associations of C-reactive protein (CRP) with: depressive and anxiety disorders; positive/negative affect; and attention, psychomotor speed, episodic memory, and executive functioning at baseline and a follow-up assessment occurring 3.91 years later ( SD  = 1.21). Additionally, we examined the association between inflammatory GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N min  = 35,300; N max  = 57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N min =22,154; N max  = 23,268). In non-genetic analyses, higher CRP was associated with depressive disorder, lower positive/higher negative affect, and worse executive function, attention, and psychomotor speed after adjusting for potential confounders. In genetic analyses, CRP GRS was associated with any anxiety disorder (β = 0.002, p  = 0.037) whereas GlycA GRS was associated with major depressive disorder (β = 0.001, p  = 0.036). Both CRP GRS (β = 0.006, p  = 0.035) and GlycA GRS (β = 0.006, p  = 0.049) were associated with greater negative affect. Inflammatory GRSs were not associated with cognition, except sIL-6R GRS which was associated with poorer memory (β = −0.009, p  = 0.018). There was a non-significant CRP-anxiety association using MR (β = 0.12; p  = 0.054). Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. These results suggest that inflammation may impact a broad range of trans-diagnostic affective symptoms.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2158-3188
2158-3188
DOI:10.1038/s41398-025-03372-w